News

AstraZeneca will present the latest clinical and real-world data across its leading inhaled, biologic and early science respiratory portfolio at the American Thoracic Society (ATS) International ...
From acid reflux to immune reactions, esophagitis has many causes—learn about its symptoms, types, and the latest treatments ...
Mepolizumab significantly reduced the annualized rate of moderate or severe exacerbations in COPD with an eosinophilic ...
Phase III trial data published in The New England Journal of Medicine support Nucala’s role as an add-on biologic therapy to ...
Here’s what to look out for. Eosinophilic esophagitis (EoE) is a chronic, inflammatory disorder of the esophagus. It occurs when immune cells called eosinophils cause inflammation in the lining ...
Proctitis causes rectal discomfort and bleeding. Learn what triggers it, how it's diagnosed, and which treatments actually ...
Mepolizumab is a humanized monoclonal antibody that targets interleukin-5, a cytokine that plays a central role in eosinophilic inflammation, which is present in 20 to 40% of patients with chronic ...
MONDAY, May 12, 2025 (HealthDay News) -- Young women taking the Pill might have an increased risk of asthma attacks, a new ...
A major study of around 260,000 women shows that taking the progesterone-only contraceptive pill can increase asthma attacks ...
With mepolizumab vs. placebo, patients with COPD and type 2 inflammation experienced significantly fewer moderate/severe ...
The study’s findings highlight a potential risk factor for younger women with asthma considering their contraceptive options ...